Record #20830

The Efficacy of the Novel Dual PI3-Kinase/mTOR Inhibitor NVP-BEZ235 Compared with Rapamycin in Renal Cell Carcinoma

Citation lifecycle

How this paper is being cited

Pre-retraction
152
Same day
1
Post-retraction
29
% post-retraction
16.0%
~16.9 citations/yr before retraction · ~4.0 citations/yr after
citing papers

Who is still citing this work

Loading…